Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology in the context of a testable cancer research hypothesis. The projects supported by this NOFO will collectively participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program.
The Cancer TEC Program will (1) catalyze the advancement of innovative, well characterized in vitro and ex vivo systems available for cancer research, (2) expand the breadth of these systems to several cancer types, and (3) promote the exploration of cancer phenomena with biomimetic tissue-engineered systems.
Deadlines:
- Letter of Intent Due Date(s): 30 days prior to the application due date
- R01 Due Date(s): Feb. 5, Jun. 5, Oct. 5
​PAR-25-171 Expiration Date May 08, 2025
This NOFO strongly encourages the use of the multi-PD/PI option given the required multidisciplinary expertise for developing and characterizing state-of-the-art biomimetic tissue-engineered technologies for understanding cancer pathophysiology in the context of a testable cancer research hypothesis.
Application budgets are limited to $400,000 Direct Costs per year. The budget should reflect the actual needs of the proposed project.
The maximum project period is 5 years. The scope of the proposed project should determine the project period.